旭通控股(01826.HK)委任吳建韶擔任主席
格隆匯12月15日丨旭通控股(01826.HK)發佈公告,2021年12月14日,董事會收到來自馮雪蓮、常亮、高雲紅及黃智成的辭任函,據此,馮雪蓮已辭任執行董事,常亮已辭任執行董事,高雲紅已辭任非執行董事,及黃智成已辭任獨立非執行董事。馮雪蓮不再擔任提名委員會成員及高雲紅不再擔任薪酬委員會成員。
董事會已議決委任吳建韶擔任主席,自2021年12月14日起生效。餘子敖已獲委任爲公司祕書,自2021年12月14日起生效。高雲紅辭任非執行董事後,不再擔任授權代表。董事會已委任餘子敖擔任授權代表,自2021年12月14日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.